ino-4212
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2015 (NCT02464670)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- EbolavirusImmunity, active
Ebolavirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ino-4212
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02464670 | Phase 1 | May 1, 2015 | Defense Advanced Research Projects Agency, GeneOne Life Science, Inovio Pharmaceuticals |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Defense Advanced Research Projects Agency | Government | 1 | 0 | 1 | 2015 |
| GeneOne Life Science | For profit | 1 | 0 | 1 | 2015 |
| Inovio Pharmaceuticals | For profit | 1 | 1 | 1 | 2015 |
3 organizations
Page 1 / 1